Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Expert Opinion on Investigational Drugs
|
March 8, 2012
Sorafenib in melanoma
Joanna Mangana, Mitchell P Levesque, Maria B Karpova, et al.
Leukemia & Lymphoma
|
September 18, 2010
Evaluation of lymphangiogenic markers in Sézary syndrome
Maria B Karpova, Kazuyasu Fujii, Daniella Jenni, et al.
International Journal of Cancer
|
July 9, 2005
Betulinic acid, a natural cytotoxic agent, fails to trigger apoptosis in human Burkitt's lymphoma-derived B-cell lines
Maria B Karpova, Duangmanee Sanmun, Jan-Inge Henter, et al.
The Journal of Investigative Dermatology
|
December 14, 2011
Cutaneous lymphomas: molecular pathways leading to new drugs
Reinhard Dummer, Simone M Goldinger, Antonio Cozzio, et al.
Oncoimmunology
|
May 8, 2015
<i>In vivo</i> profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma
Mirjana Urosevic-Maiwald, Marjam J Barysch, Phil F Cheng, et al.
International Journal of Oncology
|
February 9, 2006
Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines
Maria B Karpova, Jacqueline Schoumans, Elisabeth Blennow, et al.
Xenotransplantation
|
June 19, 2012
Complete absence of the αGal xenoantigen and isoglobotrihexosylceramide in α1,3galactosyltransferase knock-out pigs
Gisella L Puga Yung, Yunsen Li, Lubor Borsig, et al.
Dermatopathology (Basel, Switzerland)
|
April 6, 2016
Coexpression of SOX10/CD271 (p75(NTR)) and β-Galactosidase in Large to Giant Congenital Melanocytic Nevi of Pediatric Patients
Marjam J Barysch, Mitchell P Levesque, Phil Cheng, et al.
Cancer Letters
|
April 6, 2005
'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility
Evgeniya V Belogubova, Ekatherina Sh Kuligina, Alexandr V Togo, et al.
Cancer Letters
|
March 26, 2002
CYP17 genetic polymorphism in endometrial cancer: are only steroids involved?
Lev M Berstein, Evgeny N Imyanitov, Vera B Gamajunova, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Expert Opinion on Investigational Drugs
|
March 8, 2012
Sorafenib in melanoma
Joanna Mangana, Mitchell P Levesque, Maria B Karpova, et al.
Leukemia & Lymphoma
|
September 18, 2010
Evaluation of lymphangiogenic markers in Sézary syndrome
Maria B Karpova, Kazuyasu Fujii, Daniella Jenni, et al.
International Journal of Cancer
|
July 9, 2005
Betulinic acid, a natural cytotoxic agent, fails to trigger apoptosis in human Burkitt's lymphoma-derived B-cell lines
Maria B Karpova, Duangmanee Sanmun, Jan-Inge Henter, et al.
The Journal of Investigative Dermatology
|
December 14, 2011
Cutaneous lymphomas: molecular pathways leading to new drugs
Reinhard Dummer, Simone M Goldinger, Antonio Cozzio, et al.
Oncoimmunology
|
May 8, 2015
<i>In vivo</i> profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma
Mirjana Urosevic-Maiwald, Marjam J Barysch, Phil F Cheng, et al.
International Journal of Oncology
|
February 9, 2006
Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines
Maria B Karpova, Jacqueline Schoumans, Elisabeth Blennow, et al.
Xenotransplantation
|
June 19, 2012
Complete absence of the αGal xenoantigen and isoglobotrihexosylceramide in α1,3galactosyltransferase knock-out pigs
Gisella L Puga Yung, Yunsen Li, Lubor Borsig, et al.
Dermatopathology (Basel, Switzerland)
|
April 6, 2016
Coexpression of SOX10/CD271 (p75(NTR)) and β-Galactosidase in Large to Giant Congenital Melanocytic Nevi of Pediatric Patients
Marjam J Barysch, Mitchell P Levesque, Phil Cheng, et al.
Cancer Letters
|
April 6, 2005
'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility
Evgeniya V Belogubova, Ekatherina Sh Kuligina, Alexandr V Togo, et al.
Cancer Letters
|
March 26, 2002
CYP17 genetic polymorphism in endometrial cancer: are only steroids involved?
Lev M Berstein, Evgeny N Imyanitov, Vera B Gamajunova, et al.
Page
of 2